Department of Molecular Medicine, University of Padua, Padua, Italy.
Department of Biology, University of Padua, Padua, Italy.
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01596-17. Print 2017 Dec.
The emergence and spread of drug-resistant strains possibly threaten our ability to treat this disease in the future. Even though two new antitubercular drugs have recently been introduced, there is still the need to design new molecules whose mechanisms of action could reduce the length of treatment. We show that two alternative sigma factors of (SigE and SigB) have a major role in determining the level of basal resistance to several drugs and the amount of persisters surviving long-duration drug treatment. We also demonstrate that ethambutol, a bacteriostatic drug, is highly bactericidal for mutants missing either SigE or SigB. We suggest that molecules able to interfere with the activity of SigE or SigB not only could reduce virulence but also could boost the effect of other drugs by increasing the sensitivity of the organism and reducing the number of persisters able to escape killing.
耐药菌株的出现和传播可能威胁到我们未来治疗这种疾病的能力。尽管最近引入了两种新的抗结核药物,但仍有必要设计新的分子,其作用机制可以缩短治疗时间。我们表明, (SigE 和 SigB)的两种替代 sigma 因子在决定几种药物的基础耐药水平和在长时间药物治疗中存活的持久菌数量方面起着主要作用。我们还证明,乙胺丁醇,一种抑菌药物,对缺失 SigE 或 SigB 的 突变体具有高度杀菌作用。我们认为,能够干扰 SigE 或 SigB 活性的分子不仅可以降低毒力,还可以通过增加生物体的敏感性和减少能够逃避杀伤的持久菌数量来增强其他药物的效果。